Risk Assessment and

Our highly trained team here at PDS are skilled at identifying new potential risks and developing risk minimisation action plans. Preventing or mitigating these risks is at the heart of all pharmacovigilance activities throughout a product lifecycle.

Here at PDS we have the knowledge and expertise to qualify and quantitatively assess safety data, identify new safety signals and develop risk management plans (RMPs) for products in the following ways:

• Routine (monthly, bi-annual, annual) and ‘ad-hoc’ signal detection activities, generate signal reports and track signals for your products
• In-depth evaluation of potential signals by further medical analysis of case series, targeted literature search and review of data from external databases.

Call us now on +44(0) 1476 512395 to discuss your project with one of our team.